RenehaVis ™ Hyaluronic acid double-chamber
Contains 1,4ml

Hyaluronic acid double-chamber.

Hyaluronic acid double-chamber ready-to-fill syringe. Effective, safe and tolerable!

Hyaluronic acid double-chamber syringe: one chamber contains high-molecular-weight hyaluronic acid, the second chamber contains low-molecular-weight hyaluronic acid.

This method of combining two different hyaluronic acids can alleviate the consequences of arthrosis and thus postpone otherwise necessary joint operations if necessary.

In a study, RenehaVis was clearly superior to the conventional high and/or low molecular hyaluronic acids in a comparative test.

Patients have a good chance of clearly increasing the resilience of their joints due to the proven effectiveness. This increases the likelihood of being able to enjoy life to the full again and thus maintain a high quality of life.

Application: In the first year, a ¼ year dosing schedule should be followed. These are:

Day 1 1 injection per joint

Day 8 1 injection per joint

Day 15 1 injection per joint (for grade 3 and 4 knee osteoarthritis).

In the second year, the dosage schedule is half-yearly, from the third year onwards once a year.

Manufacturer: MDT Int`l Switzerland

Minimum order quantity is 30 units